Oxford Biomed Asks To Strike Invitrogen Witnesses

Law360, New York (December 2, 2008, 12:00 AM EST) -- Oxford Biomedical Research Inc. has moved to strike two of Invitrogen Corp.'s witness lists in their contract spat, arguing that Invitrogen presented the three patent and technical experts so close to the trial date that their testimony would unfairly prejudice Oxford.

By submitting its latest supplemental witness list on Nov. 25, five months before trial is set to begin, Invitrogen is trying to work around the court's Oct. 31 decision to deny its request to add patent issues to the contract dispute, Oxford claimed in a...
To view the full article, register now.